Vicapsys Life Sciences, Inc. (VICP)

USD 7.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue - 31.28 Thousand 31.32 Thousand 31.42 Thousand 31.29 Thousand 126.84 Thousand
Gross Profit - -31.28 Thousand -31.32 Thousand -31.42 Thousand -31.29 Thousand -126.84 Thousand
Operating Expenses 1.04 Million 644.55 Thousand 336.87 Thousand 765.84 Thousand 1.03 Million 1.15 Million
Selling, General and Administrative Expenses 769.08 Thousand 631.46 Thousand 319.17 Thousand 663.66 Thousand 934.92 Thousand 1.05 Million
Research and Development Expenses 15.26 Thousand 13.09 Thousand 17.69 Thousand 102.18 Thousand 98.98 Thousand 98.75 Thousand
Other Expenses 262.62 Thousand 462.68 Thousand 91.5 Thousand 286.32 Million - -
Cost and Expenses 1.04 Million 644.55 Thousand 336.87 Thousand 765.84 Thousand 1.03 Million 1.28 Million
Operating Income -1.04 Million -984.79 Thousand -336.87 Thousand -765.84 Thousand -1.03 Million -1.28 Million
Interest Expense -19.96 Thousand - - - - -
Income Tax Expense - 680.46 Thousand -100 Thousand -4.00 375.78 Thousand 917.53 Thousand
Earnings before Tax -1.18 Million -984.79 Thousand -236.87 Thousand -765.84 Thousand -1.03 Million -1.28 Million
Net Income -1.18 Million -1.66 Million -136.87 Thousand -765.84 Thousand -1.4 Million -2.2 Million
Earnings Per Share Basic -0.03 -0.05 -0.01 -0.04 -0.12 -0.23
Earnings Per Share Diluted -0.03 -0.05 -0.01 -0.04 -0.12 -0.23
Weighted Average Shares Outstanding 34.54 Million 30.57 Million 17.65 Million 17.48 Million 11.4 Million 9.46 Million
Weighted Average Shares Outstanding (Diluted) 34.54 Million 30.57 Million 17.65 Million 17.48 Million 11.4 Million 9.46 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -1.04 Million -984.79 Thousand -305.54 Thousand -734.42 Thousand -1 Million -1.15 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts